YSM News and Recognition
An innovative approach to clinical trials enrolls participants throughout the contiguous United States; researchers gain new knowledge of brain regions where paranoia may be triggered; and new insights into a retinal disorder that diminishes sight.
News
- June 14, 2024
The Yale PAX LC Trial’s decentralized, participant-centric design — developed by Harlan Krumholz, MD, and Akiko Iwasaki, PhD — makes it more efficient and cost-effective than standard clinical trials, its leaders say.
- June 14, 2024Source: YaleNews
A study has uncovered how activity in a specific region of the brain might provoke feelings of paranoia.
- June 12, 2024
Researchers have completed the first well-powered, genome-wide association study of epiretinal membrane, a common retinal disorder that often causes visual distortion or loss of visual acuity.
- June 17, 2024
As many as four out of every 10 teenagers and young adults who vape are modifying their e-cigarettes in ways that could expose them to burns, lung injury, and covert use of marijuana, a team of Yale Department of Psychiatry scientists found.
- June 18, 2024
Yale School of Medicine researchers have discovered an association between OCD and psoriasis that may have implications for dermatology practice.
- June 17, 2024
Created by the generosity of a patient's family, the endowment will ensure state-of-the-art clinical care that improves the lives of patients.
Recognition
Carson and Team Are Honored at the SNMMI Annual Meeting
Richard Carson, PhD, professor of radiology & biomedical imaging and of biomedical engineering, led a team that developed the NeuroEXPLORER, an ultra-high performance brain PET system. Based on the exceptional image quality the device produced, Carson and his team won the Image of the Year Award at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
Ferguson Is Interim Chief of Pediatric Immunology and Rheumatology
Ian Ferguson, MD, associate professor of pediatrics, will serve as interim chief of the newly formed Section of Pediatric Immunology and Rheumatology. The section will offer specialized care for patients facing conditions that arise from immune dysregulation, including a broad spectrum of rheumatologic, autoinflammatory, and autoimmune diseases. It will eventually serve patients with primary immunodeficiencies.
Hu Is Named an Aspen Ideas Health Fellow
Jiun-Ruey Hu, MD, MPH, clinical fellow (cardiovascular medicine), has been named a 2024 Aspen Ideas Health Fellow by the Aspen Institute. The fellowship is designed to bring together health care leaders who have the ability to transform ideas into action. Hu joins a diverse group of health fellows from 27 states and five other countries around the world.
McClurkin Is Named an American Psychoanalytic Association Fellow
Michael McClurkin, MD, MPP, a fourth-year resident, has been awarded a 2024-25 fellowship position with the American Psychoanalytic Association. The fellowship program is designed as an early-career initiative for future leaders and educators in academia, mental health, psychiatry, psychology, social work, and multidisciplinary endeavors.
Snyder Earns Cancer Center Lifetime Achievement Award
Edward L. Snyder, MD, professor of laboratory medicine and of pathology, has received a Yale Cancer Center Lifetime Achievement Award. Synder is honored for his “important and sustained contributions to our community” as a leader of the blood bank and transfusion medicine as well as grant review panels.
Tyagi Earns the JH Milstone Award
Tarun Tyagi, PhD, associate research scientist in the lab of John Hwa, MD, PhD, has received the JH Milstone Award, which is given annually at YSM to support early-stage investigators and innovative research that improves understanding of bleeding, thrombosis, or thrombolysis. Leonard Milstone, MD, professor emeritus of — and senior research scientist in — dermatology, established the award in honor of his late father, J. Haskell Milstone, MD, who taught pathology and blood coagulation to a generation of medical students and residents at Yale, and advocated strongly for better treatment for those with hemophilia.